Location: New York, NY
CIK: 0000078003 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 12, 2026
Total Value: $239M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORIC | ORIC PHARMACEUTICALS INC | 4,780,401 | $57.65M | 24.1% | $9.18 | +17.3% | COM | 68622P109 |
| ALLO | ALLOGENE THERAPEUTICS INC | 22,032,040 | $49.79M | 20.9% | $2.47 | -29.6% | COM | 019770106 |
| ARVN | ARVINAS INC | 3,457,815 | $34.92M | 14.6% | $24.30 | -48.3% | COM | 04335A105 |
| CELC | CELCUITY INC | 295,652 | $31.35M | 13.1% | $14.11 | +661.7% | COM | 15102K100 |
| ZURA | ZURA BIO LTD | 2,838,913 | $16.83M | 7.1% | $3.56 | +65.2% | CLASS A ORD SHS | G9TY5A101 |
| WVE | WAVE LIFE SCIENCES LTD | 1,875,000 | $11.93M | 5.0% | $13.35 | +3.0% | SHS | Y95308105 |
| PYXS | PYXIS ONCOLOGY INC | 7,032,770 | $9.213M | 3.9% | $2.88 | -46.9% | COMMON STOCK | 747324101 |
| CRBU | CARIBOU BIOSCIENCES INC | 4,690,431 | $8.349M | 3.5% | $2.01 | -19.4% | COM | 142038108 |
| SPRO | SPERO THERAPEUTICS INC | 2,362,348 | $5.504M | 2.3% | $1.19 | +99.1% | COM | 84833T103 |
| BHVN | BIOHAVEN LTD | 505,645 | $4.232M | 1.8% | $46.66 | -74.8% | COM | G1110E107 |
| CRDF | CARDIFF ONCOLOGY INC | 2,411,575 | $3.738M | 1.6% | $3.13 | -30.0% | COM | 14147L108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 953,834 | $2.003M | 0.8% | $3.28 | -20.2% | COM | 98943L107 |
| NXTC | NEXTCURE INC | 153,354 | $1.535M | 0.6% | $5.23 | +140.4% | COM NEW | 65343E207 |
| AGMB | AGOMAB THERAPEUTICS NV | 75,000 | $814K | 0.3% | $10.85 | — | ADS | 00860C102 |
| QTTB | Q32 BIO INC | 101,618 | $737K | 0.3% | $31.58 | -87.5% | COM | 746964105 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 31,305 | $137K | 0.1% | $6.62 | -13.4% | COM NEW | 097702203 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 2,928 | $17,363 | 0.0% | $8.57 | +8.8% | CL A NEW | 37611X209 |
| — | SENSEONICS HLDGS INC | 2,171 | $14,242 | 0.0% | $0.52 | — | COM | 81727U105 |